JJET致力于开发、生产和销售的产品领域的电生理学;产品主要包括三维心脏映射系统,多道生理记录仪,心脏电生理刺激,心脏射频消融设备,冷盐水灌注泵、心脏电生理导管的映射,心脏射频消融导管,神经射频治疗仪器。公司成立于1991年,总部设在成都,中国。

Rubicor医疗是一个私人医疗设备公司位于红木市,加利福尼亚。我们的专有活检技术(鼓掌乳房活检设备)是一个戏剧性的改善当前微创活检技术。14号的Ovation系统由活检设备切割的能力,捕捉和提取完整的2.5厘米直径的组织样本。热烈欢迎兼容超声波或立体定向形象指导。Rubicor由詹姆斯检查者和博士已经与私人资助的个人投资者组成的财团。詹姆斯·w .检查者,医学博士首席执行官和董事会主席,是一个委员会认证的介入心脏病学家。他是斯坦福大学医院临床医学副教授,他在那里目前活跃的员工作为社区学院。检查者博士毕业于威斯康辛医学院,他完成了一个居住在内科和心脏病的奖学金。检查者博士完成了介入性心脏病学和约翰·辛普森博士,医学博士奖学金。在红杉医院,加州雷德伍德城。 Dr. Vetter is a member of the Alpha Omega Alpha Honor Society and the American College of Cardiologists. He has published six articles and several book chapters as well as over 35 abstracts. Dr. Vetter has held positions as a member of the Physician Advisory Council and/or board member with a number of medical device companies including Guidant, Lumend, Fox Hollow and CardioVasc. He is also a board member of Magellan Systems International, Inc. Dr. Vetter has extensive experience in working with new medical device concepts and designs, working with R&D engineers to develop working prototypes and clinically testing and refining those products. He was co-founder of Perclose and was involved with that company from inception to initial public offering and eventual sale to Abbott Labs. He is a "hands on" clinician with access to resources and expertise needed to build a successful medical device and company. Dr. Vetter has had a number of patents issued in his name as co-inventor. Ary Chernomorsky, V.P. of R&D since 2000 has over 23 years experience in the medical device industry. Prior to joining Rubicor, Mr. Chernomorsky was employed by the Vascular Therapies division of US Surgical Company (acquired by Tyco International), where he served as a Director of R&D. Mr. Chernomorsky has been involved with various startup companies in the R&D Director and Manager capacities including: PAS Inc. (acquired by USS), Advanced Surgical, Inc. (acquired by Imagyn), Micro Therapeutics, Bausch and Lomb, Mentor Corporation and Dart Industries Inc. Ary holds an M.S. in Polymer Engineering from LIT and an M.S. in Biomedical Engineering from Rutgers University. Tony Difede, CPA, V.P. Finance holds a BSBA degree in Accounting from the University of Florida and a M.S. in Taxation from Pace University. He has held management positions in tax and accounting with Ernst & Young, KPMG and my CFO, Inc. His clients have included closely held start-up companies as well as large multinational public corporations. He is licensed in California and New Jersey. He has extensive experience in accounting for stock options and issues regarding closely held companies and their high net worth owners and investors. COMPANY INFO MANAGEMENT page 1 2006 Company Overview (Continued) Breast care. Completely redefined. James W. Vetter, M.D., Founder and Chairman of the Board, is a board certified interventional cardiologist. He is an Associate Professor of Clinical Medicine at Stanford University Hospital, where he is currently on Active Staff status as community faculty. Dr. Vetter is a graduate of the Medical College of Wisconsin where he completed a residency in internal medicine and a fellowship in cardiology. Dr. Vetter completed an interventional cardiology fellowship with Dr. John Simpson M.D./PhD., at Sequoia Hospital, Redwood City, Cal

哥伦比亚大学生物系统公司是一家从事分子Nano-diagnostics使用分子印迹聚合物(MIPs)等病原体的快速检测耐甲氧西林金黄色葡萄球菌(MRSA),炭疽,艾滋病毒,和锥虫病(昏睡病)。公司采用MIPs结合蛋白质,在绑定,从而改变颜色信号的存在细菌、病毒或寄生虫。

StageMark医疗保健公司,打算提供一个早期识别和炎症性疾病,如红斑狼疮的监控解决方案。

小噬细胞的使命是成为一个在全球范围内快速的细菌诊断的先驱,在细菌鉴定和药敏/电阻测试,通过其bacteriophage-based放大免疫测定诊断平台。

Flex生物医学发展技术能帮助我们找到诊断和治疗骨科疾病。Flex生物医学的主要产品是合成聚合物,Flex聚合物,用于治疗骨关节炎。